021-51111890
购物车（0）
sales@molnova.cn
TNIK-IN-3
CAS No. 2754265-25-1
TNIK-IN-3 ( —— )
产品货号. M37634 CAS No. 2754265-25-1
TNIK-IN-3 (化合物 21k) 是一种有效，选择性和具有口服活性的 TNIK 抑制剂，IC50 值为 0.026 μM。TNIK-IN-3 还可以抑制 Flt4 (IC50=0.030 μM)，Flt1 (IC50=0.191 μM) 和 DRAK1 (IC50=0.411 μM)。TNIK-IN-3 可用于结直肠癌的研究。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥1395 | 有现货 |
|
| 5MG | ￥2196 | 有现货 |
|
| 10MG | ￥3456 | 有现货 |
|
| 25MG | ￥5372 | 有现货 |
|
| 50MG | ￥7718 | 有现货 |
|
| 100MG | ￥11705 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称TNIK-IN-3
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述TNIK-IN-3 (化合物 21k) 是一种有效，选择性和具有口服活性的 TNIK 抑制剂，IC50 值为 0.026 μM。TNIK-IN-3 还可以抑制 Flt4 (IC50=0.030 μM)，Flt1 (IC50=0.191 μM) 和 DRAK1 (IC50=0.411 μM)。TNIK-IN-3 可用于结直肠癌的研究。
-
产品描述TNIK-IN-3 is a potent, selective and orally active inhibitor of Traf2- and Nck-interacting protein kinase (TNIK), with an IC50 of 0.026 μM. TNIK-IN-3 could also inhibit Flt4 (IC50=0.030 μM), Flt1 (IC50=0.191 μM) and DRAK1 (IC50=0.411 μM). TNIK-IN-3 can be used for the research of colorectal cancer.
-
体外实验TNIK-IN-3 (compound 21k) inhibits Aurora-A, GCK, and MLK3 with IC50s of 0.517 μM, 3.657 μM, and 4.552 μM, respectively.TNIK-IN-3 (0.1-100 μM; 3 days) inhibits the viability of HCT116 and DLD-1 cells, with IC50s of 4.26 μM and 8.00 μM, respectively. TNIK-IN-3 (2.5-40 μM; 10 days) dose-dependently inhibits the colony formation of HCT116 and DLD-1 cells.TNIK-IN-3 (5-20 μM; 48 h) inhibits the migration of HCT116 and DLD-1 cells.TNIK-IN-3 (5-40 μM; 48 h) dose-dependently inhibits the expression ofLRP5 and LRP6 proteins, Wnt target genes AXIN2 and c-Myc in HCT116 cells.TNIK-IN-3 (5-20 μM; 48 h) significantly suppresses the phosphorylation of JNK1/2 in Hela cells.Cell Viability Assay Cell Line:HCT116 and DLD-1 cells Concentration: 0.1-100 μM Incubation Time:3 days Result:Inhibited cell viability in a dose-dependent manner.Cell Viability Assay Cell Line:HCT116 cells Concentration:5, 10, 20, 40 μM Incubation Time:48 hours Result:Inhibited the expression of Wnt target genes AXIN2 and c-Myc, LRP5 and LRP6 proteins.
-
体内实验TNIK-IN-3 (compound 21k) (100-150 mg/kg; p.o. twice daily for 18 days) inhibits tumor growth in a dose-dependent manner.Animal Model:Six-week-old female NOD-SCID mice were injected with HCT116 cells Dosage:100, 150 mg/kg Administration:P.o. twice daily for 18 days Result:Significantly inhibited tumor growth at a dose of 150 mg/kg.
-
同义词——
-
通路Wnt/Notch/Hedgehog
-
靶点Wnt/beta/catenin
-
受体Wnt/beta-catenin
-
研究领域——
-
适应症——
化学信息
-
CAS Number2754265-25-1
-
分子量387.41
-
分子式C23H18FN3O2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 83.33 mg/mL (215.10 mM; 超声助溶 )
-
SMILESFc1ccc(CN2CCOc3cc(ccc3C2=O)-c2cnc3[nH]ccc3c2)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Li Y, et, al. Discovery of 3,4-Dihydrobenzo[ f][1,4]oxazepin-5(2 H)-one Derivatives as a New Class of Selective TNIK Inhibitors and Evaluation of Their Anti-Colorectal Cancer Effects. J Med Chem. 2022 Jan 5.?
产品手册
关联产品
-
Wnt pathway inhibito...
Wnt pathway inhibitor 3 是一种有效的 AC1 抑制剂，IC50 值为 45 nM。Wnt pathway inhibitor 3 具有抗增殖活性。
-
PRI-724 B
PRI-724 is a second-generation, selective small molecule inhibitor of the β-catenin/CBP interaction.
-
TNKS-2-IN-2
TNKS-2-IN-2 是一种有效的 TNKS2 选择性抑制剂，其 IC50 为 22 nM。
